SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-265528
Filing Date
2018-09-04
Accepted
2018-09-04 08:10:05
Documents
3
Period of Report
2018-09-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d617643d8k.htm 8-K 16955
2 EX-99.1 d617643dex991.htm EX-99.1 21800
3 GRAPHIC g617643g97d96.jpg GRAPHIC 4264
  Complete submission text file 0001193125-18-265528.txt   45877
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38276 | Film No.: 181051294
SIC: 2834 Pharmaceutical Preparations